Moderna Inc MRNA

NASDAQ US Health Care Biotechnology

$198.88 ▲ +2.08% (+$4.06)

Index member: S&P 500

🎯 52W High ⬆️ Above Yest. High

Open $195.35

Prev Close $194.82

Day Range $192.51 – $202.67

52W Range $22.28 – $195.71

Market Cap $63.11B

Beta 1.19

EPS (TTM) $-7.98

📋 Company Profile

Industry	Biotechnology
Sector	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2018-12-07
Shares Out.	396,790,000
Website	modernatx.com/ ↗
Phone	13026587581
Employees	4,700
Revenue	$145.0M
Gross Profit	$52.0M
Net Income	-$782.0M
Free Cash Flow	-$1.24B
Total Assets	$10.96B
Total Liabilities	$4.20B
Equity	$6.76B

About Moderna Inc

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna Inc is a publicly traded company under the ticker symbol MRNA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.